RUA Life Sciences is a holding company for a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM).
Positive AGM Statement
RUA Life Sciences’ AGM statement led with an update on its two revenue-generating businesses for...
Read more
FY 2022 Final Results
RUA Life Sciences’ FY 2022 results included total revenues that increased by 6% on the previous...
Read moreTrading update – the pandemic clouds disperse
RUA Life Sciences’ trading update illustrated both a recovery from the challenges of the pandemic...
Read moreFinancials reflect increased investment
RUA Life Sciences interim results demonstrated the continued investment in the business and its new...
Read moreRegulatory hiccup
RUA Life Sciences have announced a regulatory update on the 510(k) submission for its vascular...
Read moreSignificant milestone and trading update
RUA Life Sciences released a well-received announcement on an important milestone in the...
Read more
Confident AGM And Trading Update
RUA Life Sciences’ AGM statement and trading update demonstrated good progress across its...
Read more
Investing in Growth
While RUA Life Sciences’ FY 2021 results echoed some of the challenges from last year’s pandemic,...
Read moreMinor bump in the road to 510k submission
RUA have released a precautionary announcement noting a minor delay to the 510k submission for its...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
